Synthesis of silica nanocapsules: To synthesize silica nanocapsules, lyophilized SurSi peptide (Peptide 2.0 Inc., VA) was dissolved in sodium 4-(2-hydroxyethyl)-1-piperazine ethanesulfonate (HEPES) buffer (25 mм, pH 7) in the presence of ZnCl 2 (800 μм) to give a final peptide concentration of 400 μм. Then Miglyol ® 812 (20 μL) was added into 1 mL of the solution. The mixture was sonicated at 10 W (Branson Sonifier 450 ultrasonicator) for four 30 s burst and interspersed in an ice bath for 60 s. Nanoemulsion (1 mL) was dialyzed against HEPES buffer (25 mм, 500 mL, pH 7.5) at 4°C for 20 h. An aliquot of the nanoemulsion (400 μL) was transferred into a 4-mL glass vial for biosilicification reaction with tetraethoxysilane (TEOS) under magnetic stirring for up to 50 h at room temperature. To investigate the effects of reaction time and silica precursor concentration, TEOS concentration was varied and samples were taken at various times for characterization. A control vial demonstrated stability of the nanoemulsion for the reaction period.
(Branson Sonifier 450 ultrasonicator) for 60 s, and subsequently added into acetonitrile with final acetonitrile concentration of 60 v/v%, as fipronil is soluble in acetonitrile (60 v/v%) as high as 71.5 mg mL -1 , under vigorous stirring at room temperature for up to 72 h. The suspensions were centrifuged at an interval 24 h and the supernatants were collected, then fresh acetonitrile (60 v/v%) was added to the pellets. The releases of fipronil in the acetonitrile solutions were repeated until no residual fipronil in supernatants was detected.
The fipronil concentrations in the supernatants were measured by RP-HPLC as described in the following section. Then, the encapsulation efficiencies of fipronil were calculated by using Eq. S1, where C f is the fipronil concentration in release medium (mg mL -1 ), V f is the volume of release medium (mL), C i is the initial fipronil concentration in the Miglyol ® 812 oil (10 mg mL -1 ), V i is the volume of the oil phase (mL) and n is the number of repeatedrelease of fipronil.
Encapsulation Efficiency: %EE = (Eq. S1)
Sustained release study: To encapsulate fipronil, fipronil was first dissolved in Miglyol ® 812
(10 mg mL -1 ) used to form a nanoemulsion. Fipronil-loaded silica nanocapsules were then prepared by a reaction of dialyzed fipronil-loaded nanoemulsions with TEOS at concentration of 16 μmol, 32 μmol, or 96 μmol in 25 mм HEPES buffer at pH 7.5 for 30 h. The 10 mg mL -1 fipronil-loaded nanocapsules with different silica shell thicknesses were then dialyzed in water at 4°C for 20 h to remove residual TEOS. Then, the release study was started by stirring the nanocapsules aqueous solution at room temperature. At different time intervals, aliquots of 200 μL were taken, replaced with water, and the aliquots were centrifuged to obtain clear supernatant. Fipronil in the supernatant was assayed by high-performance liquid chromatography (HPLC) using a Shimadzu system equipped with a reversed-phase C18 column (Jupiter, 5 μm, 300 Å, 150 × 4.6 mm). Phosphoric acid 0.1 v/v% (A) and 90 v/v% acetonitrile, 0.1 v/v% phosphoric acid (B) were used as the mobile phases. A linear gradient from 50 to 70% B in 20 min at a flow rate of 1 mL min -1 was used with a monitoring wavelength set at 220 nm. The concentrations of fipronil released were reported relative to the saturation limit of fipronil in water (2 µg mL -1 ). To determine the concentration of fipronil, a standard curve was obtained by dissolving weighted amounts of fipronil powder in 60 v/v% acetonitrile.
Characterization: Dynamic light scattering (DLS) was performed on Malvern Zetasizer Nano ZS at a scattering angle of 173° and a temperature of 25°C. Samples were diluted by a factor of 100 prior to the size and zeta potential measurements. Transmission electron microscopy (TEM) was carried out on a JEOL 1010 operated at 100 kV. Samples (2 μL) were deposited onto Formvar-coated copper grids, washed with water and left to air-dry prior to TEM examination, without the need for staining or cryopreservation. Energy dispersive X-ray spectroscopy (EDX) spectrum were obtained by using high-resolution ( The procedure for the synthesis of silica nanocapsules by templating AM1-stabilized nanoemulsions was described in the Synthesis of silica nanocapsules (Experimental section) except that AM1 peptide was used instead of SurSi peptide. Despite the formation of silica nanocapsules by templating AM1-stabilized nanoemulsions, it led mainly to the formation of bulk silica nanoparticles (Fig. S2) indicating that the dual functionality of emulsion stabilization and silica shell formation cannot be effectively achieved by using AM1 as its surface activity is sacrificed during biosilicification reactions resulting in formation of silica largely in bulk solutions (Fig. S2 ).
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The correlograms show a typical single exponential decay of the scattered intensities over time due to the Brownian motion of the nanocapsules (Fig. S3a, c, e) . However, the correlograms of the samples of silica nanocapsules obtained after reactions with 16 µmol TEOS for 50 h (Fig. S3c) , and 32 µmol TEOS for 40 h and 50 h ( Table S1 . The number-weighted size distributions, which were calculated from the correlation functions by the zetasizer software, show only single peaks suggesting that the corresponding aggregates were present in trace amounts (Fig. S3b, d, f) . Furthermore, the time at which the correlation function starts to decay over time gives an indication of the mean size of the nanocapsules in the suspensions. Increasing reaction times between SurSistabilized nanoemulsions and TEOS produces larger silica nanocapsules which move more slowly in the suspensions and thus the correlation functions persist for longer time prior to the decay (Fig. S3a, c, e) . The number-weighted size distributions show more clearly the increase in size as the reaction times were increased (Fig. S3b, d, f) . 
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